BREAST-CANCER AND ORAL-CONTRACEPTIVES - A REVIEW

被引:14
作者
CLAVEL, F
BENHAMOU, E
SITRUKWARE, R
MAUVAISJARVIS, P
FLAMANT, R
机构
[1] INSERM,U287,F-94800 VILLEJUIF,FRANCE
[2] HOP NECKER ENFANTS MALAD,SERV ENDOCRINOL GYNECOL,F-75730 PARIS 15,FRANCE
关键词
D O I
10.1016/S0010-7824(85)80002-0
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:553 / 569
页数:17
相关论文
共 59 条
  • [1] ANDERSON TJ, 1984, LANCET, V1, P99
  • [2] [Anonymous], 1973, Lancet, V1, P1399
  • [3] BLACK MM, 1972, CANCER, V29, P338, DOI 10.1002/1097-0142(197202)29:2&lt
  • [4] 338::AID-CNCR2820290212&gt
  • [5] 3.0.CO
  • [6] 2-U
  • [7] Breslow N, 1980, STATISTICAL METHODS, V32
  • [8] ORAL-CONTRACEPTIVES AND BREAST-CANCER
    BRINTON, LA
    HOOVER, R
    SZKLO, M
    FRAUMENI, JF
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1982, 11 (04) : 316 - 322
  • [9] RISK-FACTORS FOR BENIGN BREAST DISEASE
    BRINTON, LA
    VESSEY, MP
    FLAVEL, R
    YEATES, D
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1981, 113 (03) : 203 - 214
  • [10] BRINTON LA, 1979, J NATL CANCER I, V62, P37